Myriad Genetics to Host Investor Day on September 19, 2023
17 Agosto 2023 - 5:05PM
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing
and precision medicine, will host an Investor Day at the newly
constructed Dr. Walter Gilbert Innovation Center in South San
Francisco on September 19, 2023. The in-person event will commence
with a facility tour beginning at 9:00 am PDT. The Investor Day
presentation and Q&A will take place from 10:00 am to 12:00 pm
PDT (1:00 pm to 3:00 pm EDT).
President and CEO Paul J. Diaz and other members of the Myriad
executive leadership team will discuss commercialization
strategies, clinical advancement and new product pipeline, and
long-term financial goals.
For those unable to attend in person, a live webcast of the
Investor Day presentation and Q&A will be available
at www.investor.myriad.com. A replay will be posted on Myriad
Genetics’ website after the event and will be available for at
least 30 days following.
About Myriad GeneticsMyriad Genetics is a
leading genetic testing and precision medicine company dedicated to
advancing health and well-being for all. Myriad develops and offers
genetic tests that help assess the risk of developing disease or
disease progression and guide treatment decisions across medical
specialties where genetic insights can significantly improve
patient care and lower healthcare costs. For more information,
visit www.myriad.com.
Media Contact:Glenn Farrell(801)
584-1153Glenn.Farrell@myriad.com
Investor Contact:Matt Scalo(801)
584-3532Matt.Scalo@myriad.com
Myriad Genetics (NASDAQ:MYGN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Myriad Genetics (NASDAQ:MYGN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024